Advertisement

Erkrankungen des Herzens und der Gefäße

Chapter
  • 12 Downloads

Zusammenfassung

Angeborene Herz- und Gefäßmißbildungen sind anatomisch definierte Krankheiten, die eine fehlerhafte Hämodynamik erzeugen. Die Krankheitssymptome sind Folge dieser fehlerhaften Hämodynamik. Ziel der Behandlung ist die Herstellung von Kreislaufverhältnissen, die dem Normalen gleichen oder ähneln. Da anatomisch faßbare Veränderungen durch mechanische — also chirurgische — Maßnahmen verbessert oder beseitigt werden können, ist die Behandlung i. allg. eine operative. Der Pädiater muß die Möglichkeiten der chirurgischen Behandlung angeborener und erworbener Herz- und Gefäßerkrankungen kennen, um Indikation, Zeitpunkt des Eingriffs, Optimalalter, Kontraindikation und das Risiko des Eingriffs richtig abschätzen zu können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adams HF, Emmanouilides GC, Riemenschneider TA (1989) Moss’ heart disease in infants, children and adolescents, 4th edn. Williams & Wilkins, BaltimoreGoogle Scholar
  2. 2.
    Anderson RH, Macartney FJ, Shinebourne EA, Tynan M (1987) Paediatric cardiology. Churchill Livingstone, EdinburghGoogle Scholar
  3. 3.
    Bachmann KD, Ewerbeck H, Joppich G, Kleihauer E, Rossi E, Stalder GR (1989) Pädiatrie in Praxis und Klinik, Bd I: Herz-und Kreislauferkrankungen. Fischer und Thieme, StuttgartGoogle Scholar
  4. 4.
    Beuren AJ (1966) Die angiokardiographische Darstellung kongenitaler Herzfehler. Ein Atlas. De Gruyter, BerlinGoogle Scholar
  5. 5.
    Fellows KE (1984) Therapeutic catheter procedures in congenital heart disease: Current status and future prospects. Cardiovasc Intervent Radiol 7: 170–177PubMedCrossRefGoogle Scholar
  6. 6.
    Gutheil H (1989) Kinder-EKG-Fibel, 3. Aufl. Thieme, StuttgartGoogle Scholar
  7. 7.
    Heintzen P (1963) Differentialdiagnose von Krankheitssymptomen bei Kindern und Jugendlichen. In: Catel W (Hrsg) Differentialdiagnose von Krankheitssymptomen bei Kindern und Jugendlichen, 3. Aufl. Thieme, Stuttgart, S 209Google Scholar
  8. 8.
    Kan JS, White RI jun, Mitchell SE, Anderson JH, Gardner TJ (1984) Percutaneous transluminal balloon valvuloplasty for pulmonary valve stenosis. Circulation 69: 554–560PubMedCrossRefGoogle Scholar
  9. 9.
    Keck EW (1989) Kardiologie. Neugeborene, Säuglinge, Kinder, 4. Aufl. Urban & Schwarzenberg, München Berl in WienGoogle Scholar
  10. 10.
    Keith JD, Rowe RD, Vlad P (1978) Heart disease in infancy and childhood, 3rd edn. Macmillan, New York LondonGoogle Scholar
  11. 11.
    Kramer H (1990) Prophylaxe der bakteriellen Endokarditis im Kindes-und Jugendalter. Empfehlungen der Deutschen Gesellschaft für pädiatrische Kardiologie. Kinderarzt 21: 61–63Google Scholar
  12. 12.
    Lock JE, Castaneda-Zuniga WR, Fuhrman BP, Bass JL (1983) Balloon dilatation angioplasty of hyperplastic and stenotic pulmonary arteries. Circulation 67: 962–967PubMedCrossRefGoogle Scholar
  13. 13.
    Schumacher G, Bühlmeyer K (1989) Diagnostik angeborener Herzfehler, 2. Aufl. Perimed, ErlangenGoogle Scholar
  14. 14.
    Stoermer J, Heck W (1971) Pädiatrischer EKG-Atlas, 2. Aufl. Thieme, StuttgartGoogle Scholar
  15. 1.
    Adams HF, Emmanouilides GL (1989) Moss’herart disease in infants, children and adolescents, 4th edn. Williams & Wilkins, BaltimoreGoogle Scholar
  16. 2.
    Anderson RH, Macartney FJ, Shinebourne EA, Tynan M (1987) Paediatric cardiology. Churchill Livingstone, EdinburghGoogle Scholar
  17. 3.
    Bachmann KD, Erwerbeck H, Joppich G, Kleihauer E, Rossi E, Stalder GR (1989) Pädiatrie in Praxis und Klinik, Bd I: Herz-und Kreislauferkrankungen 2. Aufl. Fischer und Thieme, StuttgartGoogle Scholar
  18. 4.
    Keck EW (1989) Kardiologie. Neugeborene, Säuglinge, Kinder, 4. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  19. 5.
    Keith JD, Rowe RD, Vlad P (1978) Heart disease in infancy and childhood, 3rd edn. Macmillan, New YorkGoogle Scholar
  20. 6.
    Watson H (ed) (1968) Paediatric cardiology. Lloyd-Luke, LondonGoogle Scholar
  21. 7.
    Wood P (1970) Disease of the heart and circulation. 3rd edn. Lippincott, PhiladelphiaGoogle Scholar
  22. 8.
    Yankah AC, Hetzer R, Miller DC, Ross DN, Somerville J, Yacoub MH (eds) (1988) Cardiac valve allografts 1962–1987. Steinkopff, DarmstadtGoogle Scholar
  23. 1.
    Adams FH, Emmanouilides GC, Riemenschneider TA (eds) (1989) Moss’ heart disease in infants, children and adolescents, 4th edn. Williams & Wilkins, BaltimoreGoogle Scholar
  24. 2.
    Anderson RH, Macartney FJ, Shinebourne EA, Tynan M (1987) Paediatric cardiology. Churchill Livingstone, EdinburghGoogle Scholar
  25. 3.
    Annales Nestlè (1984) Hypertonie beim Kind. Nestlè, Vevey, 42 /1Google Scholar
  26. 4.
    Cremer H, Rieger C (1989) Kawasaki-Syndrom–Neues zur Therapie. Pädiat Prax 38: 621–624Google Scholar
  27. 5.
    Dean RH, O’Neill JA (eds) (1983) Vascular disorders of childhood. Lea & Febiger, PhiladelphiaGoogle Scholar
  28. 6.
    Kato H, Sigeguki K, Yokoyama T (1979) Kawasaki disease: Effect of treatment on coronary artery involvement. Pediatrics 63: 175–179Google Scholar
  29. 7.
    Kawasaki T, Bühlmeyer K, Urban C, Rieger CHL, Helwig H, Schweier P, Cremer HJ (1980) Kawasaki-Syndrom. Monatsschr Kinderheilkd 128: 577–592Google Scholar
  30. 8.
    Lauer RM, Shekelle RB (eds) (1980) Childhood prevention of arterosclerosis and hypertension. Raven, New YorkGoogle Scholar
  31. 9.
    Liebermann E (1978) Hypertonie bei Kindern und Jugendlichen. Ciba-Geigy, WehrGoogle Scholar
  32. 10.
    Mains C, Wiggins J, Groves B, Clarke D (1983) Surgical therapy for a complication of Kawasaki’s disease. Ann Thorac Surg 35: 197–200PubMedCrossRefGoogle Scholar
  33. 11.
    Neufeld HN, Schneeweiss A (1983) Coronary artery disease in infants and children. Lea & Febiger, PhiladelphiaGoogle Scholar
  34. 12.
    Ulmer HE (1989) Erkrankungen des peripheren Kreislaufs. In: Bachmann KD, Erwerbeck H, Joppich G, Kleihauer E, Rossi E, Stalder G (Hrsg) Pädiatrie in Praxis und Klinik 2. Aufl., Bd I. Fischer & Thieme, Stuttgart, S 920–939Google Scholar
  35. 13.
    Vogel M, Bühlmeyer K (1989) Hypertension. In: Bachmann KD, Ewerbeck H, Joppich G, Kleihauer E, Rossi E, Stalder G (Hrsg) Pädiatrie in Praxis und Klinik 2. Aufl., Bd I. Fischer & Thieme, Stuttgart, S 912–919Google Scholar
  36. 14.
    Yankah AC, Hetzer R, Miller DC, Ross DN, Somerville J, Yacoub MH (eds) (1988) Cardiac valve allografts 1962–1987. Steinkopff, DarmstadtGoogle Scholar
  37. 1.
    Bigger JT, Hoffmann BF (1985) Antiarrhythmic drugs. In: Goodman Gilman A, Goodman LS, Pak TW, Murad F (eds) The pharmacological basis of therapeutics, 7th edn. MacMillan, New York, pp 748–783Google Scholar
  38. 2.
    Borggrefe M, Breithardt G (1985) Elektrophysiologische Wirkung von Sotalol bei supraventrikulären Tachykardien. Z Kardiol 74: 506–511PubMedGoogle Scholar
  39. 3.
    Campbell RM, Dick M, Jenkins JM et al. (1985) Atrial overdrive pacing for conversion of atrial flutter in children. Pediatrics 75: 730–736PubMedGoogle Scholar
  40. 4.
    Case CL, Trippel DL, Gillette PC (1989) New antiarrhythmic agents in pediatrics. Pediatr Clin North Am 36: 1293–1320PubMedGoogle Scholar
  41. 5.
    Crevasse L (1988) Quinidine: An update on therapeutics, pharmacokinetics and serum concentration monitoring. Am J Cardiol 62: 22–23CrossRefGoogle Scholar
  42. 6.
    Deal BJ, Keane JF, Gilette PC, Garson A (1985) WolffParkinson-White syndrome and supraventricular tachycardia during infancy: Management and followup. J Am Coll Cardiol 5: 130–135PubMedCrossRefGoogle Scholar
  43. 7.
    Dick M, Campbell RM (1984) Advances in the management of cardiac arrhythmias in children. Pediatr Clin North Am 31: 1175–1195PubMedGoogle Scholar
  44. 8.
    Garson A (1986) Dosing the newer antiarrhythmic drugs in children: Considerations in pediatric pharmacology. Am J Cardiol 57: 1405–1407PubMedCrossRefGoogle Scholar
  45. 9.
    Gillette PC (1985) Supraventricular arrhythmias in children. J Am Coll Cardiol 5: 122–129CrossRefGoogle Scholar
  46. 10.
    Gillette PC (1989) Advances in treatment of supraventricular tachydysrhythmias in children. Mod Conc Cardiovase Dis 58: 37–41Google Scholar
  47. 11.
    Greene HL (1989) The efficacy of amiodarone in the treatment of ventricular tachycardia or ventricular fibrillation. Progr Cardiovasc Dis 31: 319–354CrossRefGoogle Scholar
  48. 12.
    Kreeger RW, Hammill SC (1987) New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodaronc. Mayo Clin Proc 62: 1033–1050PubMedCrossRefGoogle Scholar
  49. 13.
    Kugler JD, Donford DA (1989) Pacemakers in children: An update. Am Heart J 117: 665–679Google Scholar
  50. 14.
    Luderitz B (1986) Wirkungsspektrum der Betarezeptorenblockade bei Herzrhythmusstörungen. Z Kardiol 75 (Suppl 5): 41–46PubMedGoogle Scholar
  51. 15.
    Mitchell LB, Wyse DG, Duff HJ (1987) Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome. Circulation 76: 810–818PubMedCrossRefGoogle Scholar
  52. 16.
    Moak JP, Smith RT, Garson A jr (1987) Newer anti-arrhythmic drugs in children. Am Heart J 113: 179–185PubMedCrossRefGoogle Scholar
  53. 17.
    Musto B, D’Onofrio A, Cavallaro C, Musto A (1988) Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supra-ventricular tachycardia. Circulation 78: 863–869PubMedCrossRefGoogle Scholar
  54. 18.
    Perry JC, McQuinn RL, Smith RT, Gothing C, Fredell P, Garson A (1989) Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol 14: 185–191PubMedCrossRefGoogle Scholar
  55. 19.
    Schmidt G, Honerjäger P, Niesel T (1989) Hämodynamische Wirkungen von Klasse-I- and Klasse-III-Antiarrhythmika. Dtsch Med Wochenschr 114: 1040–1045PubMedCrossRefGoogle Scholar
  56. 20.
    Singh BN, Collett JT, Chew CYC (1980) New perspectives in the pharmacologic therapy of cardiac arrhythmias. Progr Cardiovasc Diss 22: 243–301CrossRefGoogle Scholar
  57. 21.
    Torres V, Flowers D, Somberg JC (1985) The arrhythmogenicity of antiarrhythmic agents. Am Heart J 109: 1090–1097PubMedCrossRefGoogle Scholar
  58. 22.
    Webb CL, Dick M, Rocchini AP et al. (1987) Quinidine syncope in children. J Am Coll Cardiol 9: 1031–7PubMedCrossRefGoogle Scholar
  59. 23.
    Williams EMV (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24: 129–147CrossRefGoogle Scholar
  60. 24.
    Woosley RL (1988) Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugs. Am J Cardiol 62: 9–17CrossRefGoogle Scholar
  61. 25.
    Ziegler V, Gilette PC, Ross BA, Ewing L (1988) Flecainide for supraventricular and ventricular arrhythmias in children and young adults. Am J Cardiol 62: 818–820CrossRefGoogle Scholar
  62. 26.
    Zipes DP (1989) Cardiac electrophysiology: Promises and contributions. J Am Coll Cardiol 13: 1329–1352PubMedCrossRefGoogle Scholar
  63. 1.
    Beekman RH, Rocchini AP, Dick M, Croeley DC, Rosenthal A (1984) Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation. Pediatrics 73: 43PubMedGoogle Scholar
  64. 2.
    Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P (1985) Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 106: 102PubMedCrossRefGoogle Scholar
  65. 3.
    Brunner HR, Waeber B, Nussberger J (1987) Die ACE-Hemmer and ihre klinische Bedeutung. Herz 12 (Suppl I): 3PubMedGoogle Scholar
  66. 4.
    Chatterjee K, De Marco T, Rouleau JL (1988) Vasodilator therapy in chronic congestive heart failure. Am J Cardiol 62: 46AGoogle Scholar
  67. 5.
    Cohn JN (1988) Current therapy of the failing heart. Circulation 78: 1099PubMedCrossRefGoogle Scholar
  68. 6.
    Colucci WS, Wright RF, Braunwald E (1986) New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (part one). N Engl J Med 314: 290Google Scholar
  69. 7.
    Colucci WS, Wright RF, Braunwald E (1986) New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments (part two). N Engl J Med 314: 349Google Scholar
  70. 8.
    Francis GS (1988) Neuroendocrine manifestations of congestive heart failure. Am J Cardiol 62: 9AGoogle Scholar
  71. 9.
    Fricker FJ, Bartley PP, Hardesty RL et al. (1987) Experience with heart transplantation in children. Pediatrics 79: 138PubMedGoogle Scholar
  72. 10.
    Friedman WF, George BL (1984) New concepts and drugs in the treatment of congestive heart failure. Pediatr Clin North Am 31: 1197PubMedGoogle Scholar
  73. 11.
    Goodman Gilman A, Goodman LS, Pak TW, Murad F (eds) (1985) The pharmacological basis of therapeutics, 7th edn. MacMillan, New YorkGoogle Scholar
  74. 12.
    Hastreiter AR, van der Horst RL, Voda C, Chow-Tung E (1985) Maintenance digoxin dosage and steady-state plasma concentration in infants and children. J Pediatr 107: 140PubMedCrossRefGoogle Scholar
  75. 13.
    Katz AM (1989) Changing strategies in the management of heart failure. J Am Coll Cardiol 13: 513PubMedCrossRefGoogle Scholar
  76. 14.
    Katz AM (1989) The myocardium in congestive heart failure. Am J Cardiol 63: 12AGoogle Scholar
  77. 15.
    Koren G (1985) Interaction between digoxin and commonly coadministered drugs in children. Pediatrics 75: 1032PubMedGoogle Scholar
  78. 16.
    Levine TB (1985) Role of vasodilators in the treatment of congestive heart failure. Am J Cardiol 55: 32AGoogle Scholar
  79. 17.
    Mofenson HC, Carracio TR, Schauben J (1986) Poisoning by antidysrhythmic drugs. Pediatr Clin North Am 33: 723PubMedGoogle Scholar
  80. 18.
    Packer M (1986) Neurohumoral interactions and adaptations in congestive heart failure. Circulation 77: 721CrossRefGoogle Scholar
  81. 19.
    Park MK (1986) Use of digoxin in infants and children with specific emphasis on dosage. J Pediatr 108: 871PubMedCrossRefGoogle Scholar
  82. 20.
    Parmley WW (1985) Pathophysiology of congestive heart failure. Am J Cardiol 45: 9AGoogle Scholar
  83. 21.
    Schneeweiss A (1986) Drug therapy in infants and children with cardiovascular diseases. Lea & Febinger, PhiladelphiaGoogle Scholar
  84. 22.
    Taylor SH (1985) Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future. Z Kardiol 74 (Suppl 2): 2PubMedGoogle Scholar
  85. 23.
    Witte MK, Stork JE, Blumer JL (1986) Diuretic therapeutics in the pediatric patient. Am J Cardiol 57: 44AGoogle Scholar
  86. 24.
    Zaritzky A, Chernow B (1984) Use of catecholamines in pediatrics. J Pediatr 105: 341CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

There are no affiliations available

Personalised recommendations